SSX8 Antikörper (C-Term)

Produktnummer ABIN928571

Der Kaninchen-Polyklonal Anti-SSX8-Antikörper wurde für WB validiert. Er ist geeignet zum Nachweis von SSX8 in Proben aus Human. }

Kurzübersicht für SSX8 Antikörper (C-Term) (ABIN928571)

Target: SSX8 (Synovial Sarcoma, X Breakpoint 8 (SSX8))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SSX8 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-SSX8 Antikörper

Bindungsspezifität: C-Term

Aufreinigung: Purified

Immunogen: SSX8 antibody was raised in rabbit using the C terminal of SSX8 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

SSX8 Blocking Peptide, (ABIN5616401), is also available for use as a blocking control in assays to test for specificity of this SSX8 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu SSX8

Target: SSX8 (Synovial Sarcoma, X Breakpoint 8 (SSX8))

Andere Bezeichnung: SSX8

Hintergrund: SSX8 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. Synonyms: Polyclonal SSX8 antibody, Anti-SSX8 antibody, synovial sarcoma, X breakpoint 8 antibody.